Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.50
-0.73 (-4.79%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $882.06 million as of April 29, 2026. Its market cap has decreased by -44.46% in one year.
Market Cap
882.06M
Enterprise Value
-62.37M
1-Year Change
-44.46%
Ranking
Category
Stock Price
$14.50
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $882.06M, an increase of 43.72%. That is a compound annual growth rate of 7.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 926.47M | 11.62% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 908.18M |
| Maravai LifeSciences Holdings | 907.45M |
| CytomX Therapeutics | 903.43M |
| Phathom Pharmaceuticals | 902.33M |
| LB Pharmaceuticals | 897.26M |
| Xencor | 885.20M |
| Bright Minds Biosciences | 873.45M |
| SELLAS Life Sciences Group | 869.18M |